SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-007991
Filing Date
2024-05-13
Accepted
2024-05-13 17:10:36
Documents
78
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q lqda-20240331x10q.htm   iXBRL 10-Q 1625872
2 EX-31.1 lqda-20240331xex31d1.htm EX-31.1 15298
3 EX-31.2 lqda-20240331xex31d2.htm EX-31.2 15327
4 EX-32.1 lqda-20240331xex32d1.htm EX-32.1 7560
5 EX-32.2 lqda-20240331xex32d2.htm EX-32.2 7567
6 GRAPHIC lqda-20240331x10q002.jpg GRAPHIC 631
  Complete submission text file 0001558370-24-007991.txt   7373805

Data Files

Seq Description Document Type Size
7 EX-101.SCH lqda-20240331.xsd EX-101.SCH 69705
8 EX-101.CAL lqda-20240331_cal.xml EX-101.CAL 44123
9 EX-101.DEF lqda-20240331_def.xml EX-101.DEF 194032
10 EX-101.LAB lqda-20240331_lab.xml EX-101.LAB 521810
11 EX-101.PRE lqda-20240331_pre.xml EX-101.PRE 358314
82 EXTRACTED XBRL INSTANCE DOCUMENT lqda-20240331x10q_htm.xml XML 1172515
Mailing Address 419 DAVIS DRIVE, SUITE 100 MORRISVILLE NC 27560
Business Address 419 DAVIS DRIVE, SUITE 100 MORRISVILLE NC 27560 919.328.4400
Liquidia Corp (Filer) CIK: 0001819576 (see all company filings)

IRS No.: 851710962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39724 | Film No.: 24940243
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)